title: Facial hypertrichosis induced by Cetuximab, an anti-EGFR monoclonal antibody.
authors.forename: Delphine
authors.initials: D
authors.lastname: Kerob
authors.forename: Alain
authors.initials: A
authors.lastname: Dupuy
authors.forename: Pascal
authors.initials: P
authors.lastname: Reygagne
authors.forename: Annabelle
authors.initials: A
authors.lastname: Levy
authors.forename: Patrice
authors.initials: P
authors.lastname: Morel
authors.forename: Bruno A
authors.initials: BA
authors.lastname: Bernard
authors.forename: Céleste
authors.initials: C
authors.lastname: Lebbé
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary; D000068818:Cetuximab; D066246:ErbB Receptors; D005145:Face; D005260:Female; D006801:Humans; D006983:Hypertrichosis / Q000139:chemically induced* / Q000473:pathology; D007866:Leg; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab